Grace Therapeutics, Inc. Depreciation
Grace Therapeutics, Inc. (GRCE) reported Depreciation of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- Grace Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $2.00K, a 0.00% change year-over-year.
- Grace Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $2.00K, a 0.00% change year-over-year.
- Grace Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $3.00K, a 50.00% increase year-over-year.
- Grace Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. depreciation for fiscal 2026 was $7.00K, a 0.00% change from fiscal 2025.
- Grace Therapeutics, Inc. depreciation for fiscal 2025 was $7.00K, a 36.36% decline from fiscal 2024.
- Grace Therapeutics, Inc. depreciation for fiscal 2024 was $11.00K, a 91.13% decline from fiscal 2023.
- Grace Therapeutics, Inc. depreciation for fiscal 2023 was $124.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-13 | $4.00K derived: sum of 2 quarters · filed 2026-08-13 | $7.00K derived: sum of 3 quarters · filed 2026-08-13 | $7.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $5.00K derived: sum of 2 quarters · filed 2026-06-18 | $5.00K derived: sum of 3 quarters · filed 2026-06-18 | $7.00K 10-K · filed 2026-06-18 |
| 2025-12-31 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $3.00K derived: sum of 2 quarters · filed 2026-02-12 | $5.00K 10-Q · filed 2026-02-12 | $7.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $2.00K 10-Q · filed 2025-11-13 | $4.00K derived: sum of 3 quarters · filed 2026-08-13 | $6.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-13 | $4.00K derived: sum of 2 quarters · filed 2026-08-13 | $6.00K derived: sum of 3 quarters · filed 2026-08-13 | $8.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $4.00K derived: sum of 2 quarters · filed 2026-06-18 | $6.00K derived: sum of 3 quarters · filed 2026-06-18 | $7.00K 10-K · filed 2026-06-18 |
| 2024-12-31 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $4.00K derived: sum of 2 quarters · filed 2026-02-12 | $5.00K 10-Q · filed 2026-02-12 | $6.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $3.00K 10-Q · filed 2025-11-13 | $4.00K derived: sum of 3 quarters · filed 2025-11-13 | $5.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.00K 10-Q · filed 2025-08-12 | $2.00K derived: sum of 2 quarters · filed 2025-08-12 | $3.00K derived: sum of 3 quarters · filed 2025-08-12 | $5.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-23 | $2.00K derived: sum of 2 quarters · filed 2025-06-23 | $4.00K derived: sum of 3 quarters · filed 2025-06-23 | $11.00K 10-K · filed 2025-06-23 |
| 2023-12-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $3.00K derived: sum of 2 quarters · filed 2025-02-13 | $10.00K 10-Q · filed 2025-02-13 | $18.00K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-13 | $9.00K 10-Q · filed 2024-11-13 | $17.00K derived: sum of 3 quarters · filed 2024-11-13 | $27.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $7.00K 10-Q · filed 2024-08-09 | $15.00K derived: sum of 2 quarters · filed 2024-08-09 | $25.00K derived: sum of 3 quarters · filed 2024-08-09 | -$36.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $18.00K derived: sum of 2 quarters · filed 2024-06-21 | -$43.00K derived: sum of 3 quarters · filed 2024-06-21 | $124.00K 10-K · filed 2024-06-21 |
| 2022-12-31 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | -$51.00K derived: sum of 2 quarters · filed 2024-02-12 | $116.00K 10-Q · filed 2024-02-12 | $116.00K derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | -$61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $106.00K 10-Q · filed 2023-11-13 | $106.00K derived: sum of 3 quarters · filed 2023-11-13 | $106.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $167.00K 10-Q · filed 2023-08-11 | $167.00K derived: sum of 2 quarters · filed 2023-08-11 | $167.00K derived: sum of 3 quarters · filed 2023-08-11 | $167.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | $0.00 derived: sum of 2 quarters · filed 2023-06-23 | $0.00 derived: sum of 3 quarters · filed 2023-06-23 | $0.00 10-K · filed 2023-06-23 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-14 | $0.00 derived: sum of 2 quarters · filed 2022-02-14 | $0.00 10-Q · filed 2023-02-14 | $1.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $1.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | $1.00K derived: sum of 2 quarters · filed 2022-08-11 | $1.00K derived: sum of 3 quarters · filed 2022-08-11 | $57.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | $1.00K derived: sum of 2 quarters · filed 2022-06-21 | $57.00K derived: sum of 3 quarters · filed 2022-06-21 | $143.00K 10-K · filed 2022-06-21 |
| 2020-12-31 | $0.00 10-Q · filed 2022-02-14 | $56.00K derived: sum of 2 quarters · filed 2022-02-14 | $142.00K 10-Q · filed 2022-02-14 | $552.00K derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | $56.00K 10-Q · filed 2021-11-10 | $142.00K 10-Q · filed 2021-11-10 | $552.00K derived: sum of 3 quarters · filed 2021-11-10 | $662.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $86.00K 10-Q · filed 2021-08-12 | $496.00K derived: sum of 2 quarters · filed 2021-08-12 | $606.00K derived: sum of 3 quarters · filed 2021-08-12 | $678.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $410.00K 10-K · filed 2020-06-29 | $520.00K derived: sum of 2 quarters · filed 2021-02-09 | $592.00K derived: sum of 3 quarters · filed 2021-02-09 | $410.00K 10-K · filed 2021-06-22 |
| 2019-12-31 | $110.00K 10-Q · filed 2021-02-09 | $182.00K derived: sum of 2 quarters · filed 2021-02-09 | $271.00K 10-Q · filed 2021-02-09 | $655.00K derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-09-30 | $72.00K 10-Q · filed 2020-11-16 | $161.00K 10-Q · filed 2020-11-16 | $545.00K derived: sum of 3 quarters · filed 2020-11-16 | |
| 2019-06-30 | $89.00K 10-Q · filed 2020-08-13 | $473.00K derived: sum of 2 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $384.00K 10-K · filed 2020-06-29 | $384.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |